No abstract

Redox potentials of photosensitive cyclometalated RuII derivatives of 2-phenylpyridine or 2-(4-tolyl)pyridine are controllably decreased by up to 0.8 V within several minutes. This is achieved by irradiation of the ruthena(II)cycles cis-[Ru(o-X-2-py)(LL)(MeCN)2]PF6 (2, X = C6H4 (a) or 4-MeC6H3 (b), LL = 1,10-phenanthroline or 2,2'-bipyridine). The cis geometry of the MeCN ligands has been confirmed by the X-ray structural studies. The sigma-bound sp2 carbon of the metalated ring is trans to LL nitrogen. Complexes 2 are made from [Ru(o-X-2-py)(MeCN)4]PF6 (1) and LL. This "trivial" ligand substitution is unusual because 1a reacts readily with phen in MeCN as solvent to give cis-[Ru(o-C6H4-2-py)(phen)(MeCN)2]PF6 (2c) in a 83% yield, but bpy does not afford the bpy-containing 2 under the same conditions. cis-[Ru(o-C6H4-2-py)(bpy)(MeCN)2]PF6 (2e) has been prepared in CH2Cl2 (74%). Studies of complexes 2c,e by cyclic voltammetry in MeOH in the dark reveal RuII/III quasy-reversible redox features at 573 and 578 mV (vs Ag/AgCl), respectively. A minute irradiation 2c and 2e converts them into new species with redox potentials of -230 and 270 mV, respectively. An exceptional potential drop for 2c is accounted for in terms of a photosubstitution of both MeCN ligands by methanol. ESR, 1H NMR, and UV-vis data indicate that the primary product of photolysis of 2c is an octahedral monomeric low-spin (S = 1/2) RuIII species, presumably cis-[RuIII(o-C6H4-2-py)(phen)(MeOH)2]2+. The primary photoproduct of bpy complex 2e is cis-[RuII(o-C6H4-2-py)(bpy)(MeCN)(MeOH)]+, and this accounts for a lower decrease in the redox potential. Irradiation of 2c in the presence of added chloride affords [(phen)(o-C6H4-2-py)ClRuIIIORuIVCl(o-C6H4-2-py)(phen)]PF6, a first mu-oxo-bridged mixed valent dimer with a cyclometalated unit. The structure of the dimer has been established by X-ray crystallography.

No abstract

A library of 19 cycloruthenated derivatives is constructed by making use of the well‐known cyclometalation reaction. Their geometries are modified in a straightforward manner by addition of either mono‐ or bidentate ligands, such as bipyridine, phenanthroline, 1,2‐bis(diphenylphosphanyl)ethane, dimethylphenylphosphane, triphenylphosphane, and 1,3,5‐triaza‐7‐phosphatricyclo[3.3.1.1]decane (PTA) ligands, to cationic cycloruthenated centers. The antitumor properties of the compounds thus obtained are investigated in order to compare them with recently reported ruthenium complexes and cisplatin. IC50 values against mammalian cells (A‐172, HCT‐116, and RDM‐4) are determined for the library compounds and some of them, such as those derived from orthoruthenated phenylpyridine and a bidentate N,N ligand, display activity of the same order of magnitude as cisplatin. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)

A versatile photoactivated catalytic system based on a cyclometalated ruthenium(II) complex, composed of strongly coordinating bidentate and relatively labile ligands, in conjunction with a traditional alkyl bromide initiator, has been developed for living/controlled radical polymerization. Polymerizations of three typical hydrophobic monomersmethyl methacrylate (MMA), styrene (St), and n-butyl acrylate (BA)proceeded to high conversions under visible light irradiation. The polymerization process was photoresponsive, i.e., took place only under irradiation and immediately stopped when the light was turned off. Block copolymers of MMA with St and BA with St, as well as statistical copolymer of BA and St, could also be conveniently prepared. 1 H NMR and electrochemical studies suggest a mechanism of the catalytic activation, which involves a photoinduced formation of the solvento 18-electron species cis-[Ru(o-C 6 H 4 -2-py)(phen)(MeCN)(acetone)] + through the intermediacy of the 16-electron five-coordinated complex cis-[Ru(o-C 6 H 4 -2-py)(phen)(MeCN)] + which is believed to be a crucial intermediate of the overall ATRP process.